UMAC Fundamental Analysis - UNUSUAL MACHINES INC /US

Name: UNUSUAL MACHINES INC /US (UMAC) Stock
Brand: UNUSUAL MACHINES INC /US
Rating: 4.5 (3 reviews)

Fundamental Rating

Taking everything into account, UMAC scores 4 out of 10 in our fundamental rating. UMAC was compared to 123 industry peers in the Electronic Equipment, Instruments & Components industry. No worries on liquidiy or solvency for UMAC as it has an excellent financial health rating, but there are worries on the profitability. UMAC is valied quite expensively at the moment, while it does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year UMAC has reported negative net income.

UMAC had a negative operating cash flow in the past year.

In the past 5 years UMAC always reported negative net income.

UMAC had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

UMAC's Return On Assets of -75.30% is on the low side compared to the rest of the industry. UMAC is outperformed by 91.06% of its industry peers.

The Return On Equity of UMAC (-76.97%) is worse than 78.86% of its industry peers.

		Industry Rank	Sector Rank
ROA	-75.3%
ROE	-76.97%
ROIC	N/A

ROA(3y)-130.57%

ROA(5y)-90.46%

ROE(3y)-141%

ROE(5y)-96.71%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

UMAC has a Gross Margin of 29.15%. This is comparable to the rest of the industry: UMAC outperforms 45.53% of its industry peers.

UMAC's Gross Margin has declined in the last couple of years.

The Profit Margin and Operating Margin are not available for UMAC so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	29.15%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-34.75%

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

UMAC does not have a ROIC to compare to the WACC, probably because it is not profitable.

UMAC has more shares outstanding than it did 1 year ago.

There is no outstanding debt for UMAC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

UMAC has an Altman-Z score of 156.33. This indicates that UMAC is financially healthy and has little risk of bankruptcy at the moment.

UMAC has a Altman-Z score of 156.33. This is amongst the best in the industry. UMAC outperforms 100.00% of its industry peers.

There is no outstanding debt for UMAC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	156.33

ROIC/WACCN/A

WACC9.14%

2.3 Liquidity

A Current Ratio of 51.38 indicates that UMAC has no problem at all paying its short term obligations.

With an excellent Current ratio value of 51.38, UMAC belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.

UMAC has a Quick Ratio of 49.43. This indicates that UMAC is financially healthy and has no problem in meeting its short term obligations.

Looking at the Quick ratio, with a value of 49.43, UMAC belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	51.38
Quick Ratio	49.43

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for UMAC have decreased strongly by -717.95% in the last year.

UMAC shows a strong growth in Revenue. In the last year, the Revenue has grown by 279.39%.

The Revenue has been growing by 936.35% on average over the past years. This is a very strong growth!

EPS 1Y (TTM)-717.95%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-99.19%

Revenue 1Y (TTM)279.39%

Revenue growth 3Y936.35%

Revenue growth 5YN/A

Sales Q2Q%50.52%

3.2 Future

UMAC is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.34% yearly.

Based on estimates for the next years, UMAC will show a very strong growth in Revenue. The Revenue will grow by 85.70% on average per year.

EPS Next Y5.43%

EPS Next 2Y28.16%

EPS Next 3Y16.34%

EPS Next 5YN/A

Revenue Next Year31.18%

Revenue Next 2Y79.89%

Revenue Next 3Y99.35%

Revenue Next 5Y85.7%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for UMAC. In the last year negative earnings were reported.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for UMAC. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

UMAC's earnings are expected to grow with 16.34% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y28.16%

EPS Next 3Y16.34%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

UMAC does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

UNUSUAL MACHINES INC /US

NYSEARCA:UMAC (11/14/2025, 8:04:00 PM)

After market: 9.45 +0.1 (+1.07%)

9.35

-0.3 (-3.11%)

Chartmill FA Rating

GICS SectorInformation Technology

GICS IndustryGroupTechnology Hardware & Equipment

GICS IndustryElectronic Equipment, Instruments & Components

Earnings (Last)11-06 2025-11-06/amc

Earnings (Next)N/A N/A

Inst Owners12.16%

Inst Owner Change6.2%

Ins Owners6.86%

Ins Owner Change3.27%

Market Cap289.57M

Revenue(TTM)7.70M

Net Income(TTM)-39.49M

Analysts82.22

Price Target20.74 (121.82%)

Short Float %8.14%

Short Ratio0.66

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)0

Avg EPS beat(2)-194.93%

Min EPS beat(2)-318.3%

Max EPS beat(2)-71.57%

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)2

Avg Revenue beat(2)17.04%

Min Revenue beat(2)14.93%

Max Revenue beat(2)19.14%

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)19.61%

PT rev (3m)12.96%

EPS NQ rev (1m)136.36%

EPS NQ rev (3m)143.08%

EPS NY rev (1m)23.79%

EPS NY rev (3m)-23.75%

Revenue NQ rev (1m)-12.4%

Revenue NQ rev (3m)-18.28%

Revenue NY rev (1m)6.49%

Revenue NY rev (3m)-0.81%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	37.6
P/FCF	N/A
P/OCF	N/A
P/B	5.64
P/tB	6.94
EV/EBITDA	N/A

EPS(TTM)-3.52

EYN/A

EPS(NY)-0.17

Fwd EYN/A

FCF(TTM)-0.19

FCFYN/A

OCF(TTM)-0.18

OCFYN/A

SpS0.25

BVpS1.66

TBVpS1.35

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-75.3%
ROE	-76.97%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	29.15%
FCFM	N/A

ROA(3y)-130.57%

ROA(5y)-90.46%

ROE(3y)-141%

ROE(5y)-96.71%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-34.75%

GM growth 5YN/A

F-Score4

Asset Turnover0.15

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	51.38
Quick Ratio	49.43
Altman-Z	156.33

F-Score4

WACC9.14%

ROIC/WACCN/A

Cap/Depr(3y)189.42%

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-717.95%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-99.19%

EPS Next Y5.43%

EPS Next 2Y28.16%

EPS Next 3Y16.34%

EPS Next 5YN/A

Revenue 1Y (TTM)279.39%

Revenue growth 3Y936.35%

Revenue growth 5YN/A

Sales Q2Q%50.52%

Revenue Next Year31.18%

Revenue Next 2Y79.89%

Revenue Next 3Y99.35%

Revenue Next 5Y85.7%

EBIT growth 1Y-329.32%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year-7.96%

EBIT Next 3Y35.96%

EBIT Next 5Y43.44%

FCF growth 1Y-190.76%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-178.19%

OCF growth 3YN/A

OCF growth 5YN/A

UNUSUAL MACHINES INC /US / UMAC FAQ

What is the ChartMill fundamental rating of UNUSUAL MACHINES INC /US (UMAC) stock?

ChartMill assigns a fundamental rating of 4 / 10 to UMAC.

What is the valuation status for UMAC stock?

ChartMill assigns a valuation rating of 0 / 10 to UNUSUAL MACHINES INC /US (UMAC). This can be considered as Overvalued.

What is the profitability of UMAC stock?

UNUSUAL MACHINES INC /US (UMAC) has a profitability rating of 0 / 10.

UNUSUAL MACHINES INC /US (UMAC) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

UNUSUAL MACHINES INC /US / UMAC FAQ

What is the ChartMill fundamental rating of UNUSUAL MACHINES INC /US (UMAC) stock?

What is the valuation status for UMAC stock?

What is the profitability of UMAC stock?